The goal of the treatment of Cushing's syndrome is rapid normalization of the negative metabolic effects and biochemical abnormalities associated with the disorder. Treatment is ultimately ...

This medication is teratogenic and is not currently approved for use in the treatment of Cushing's syndrome. [51] ACTH: Adrenocorticotrophic hormone; b.i.d.: Twice daily; GI: Gastrointestinal ...

Concomitant medication can contribute to the diagnostic inaccuracy of the combined dexamethasone–corticotropin-releasing hormone (CRH) test in Cushing syndrome. The ability to differentiate ...

Cushing syndrome can be endogenous—meaning, it happens from within your body—or exogenous, which means it’s caused by outside ...

Shares of Corcept Therapeutics Incorporated CORT have rallied 60.7% in the past three months against the industry’s decline ...

The US FDA has approved a new orphan drug to treat patients with Cushing’s disease who cannot be helped through surgery. Novartis’ Signifor (pasireotide diaspartate) injection has been ...

Total third-quarter revenue of $54 million was led by triple-digit percentage growth of sales of Recorlev, a cortisol ...

The standard test for differentiating between pituitary and ectopic adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome is corticotropin-releasing hormone (CRH)-stimulated inferior ...

Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and immunology, today announced that the Phase ...

PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and ...